| 注册
首页|期刊导航|世界中西医结合杂志|通脉养心丸治疗冠心病心律失常的Meta分析

通脉养心丸治疗冠心病心律失常的Meta分析

邱璐 丁宇坤 王显

世界中西医结合杂志2025,Vol.20Issue(10):1916-1924,9.
世界中西医结合杂志2025,Vol.20Issue(10):1916-1924,9.DOI:10.13935/j.cnki.sjzx.251002

通脉养心丸治疗冠心病心律失常的Meta分析

Meta-analysis of the Treatment of Arrhythmia in Coronary Heart Disease with Tongmai Yangxin Pills

邱璐 1丁宇坤 2王显3

作者信息

  • 1. 北京中医药大学东直门医院心内科,北京 100700
  • 2. 北京市丰台区中西医结合医院,北京 100076
  • 3. 北京中医药大学东直门医院心内科,北京 100700||北京中医药大学心血管病研究所,北京 100700
  • 折叠

摘要

Abstract

Objective To systematically evaluate the efficacy and safety of Tongmai Yangxin Pills(TMYXP)in the treatment of coronary heart disease(CHD)with arrhythmias.Methods Eight databases,including CNKI,Wanfang Da-ta,VIP,PubMed,Web of Science,SinoMed,and The Cochrane Library,were searched from their inception to October 1,2024.Literature screening and quality assessment were conducted independently by two reviewers.Statistical analysis was performed using Review Manager 5.4(RevMan 5.4).Results Twenty randomized controlled trials(RCTs)involving a to-tal of 2 459 patients were included.Compared with conventional therapy alone,TMYXP combined with standard treatment significantly improved clinical symptom efficacy[relative risk RR=1.26,95%confidence interval CI(1.21-1.31),I2=0%,P<0.000 01],enhanced traditional Chinese medicine(TCM)syndrome efficacy[RR=1.38,95%CI(1.21-1.58),I2=0%,P<0.000 01],improved TCM syndrome scores[RR=-2.71,95%CI(-3.07 to-2.35),I2=71%,P<0.000 01],effectively controlled mean ventricular rate[mean difference MD=-6.17,95%CI(-7.8 to-4.54),I2=0%,P<0.000 01],decreased the frequency of CHD arrhythmia episodes[RR=-5.57,95%CI(-6.42 to-4.73),I2=0%,P<0.000 01],reduced the number of premature atrial contractions[Standardized mean difference,SMD=-9.02,95%CI(-9.81,-8.22),I2=0,P<0.000 01],improved 6-minute walk distance(6MWD)[MD=66.11,95%CI(58.27-73.95),I2=71%,P<0.000 01],and lowered the incidence of adverse events[RR=0.41,95%CI(0.26-0.65),I2=0%,P=0.000 1].Conclusion On the basis of conventional Western medical treatment for CHD with arrhythmias,combining TMYXP significantly enhances clinical efficacy and demonstrates good safety.

关键词

通脉养心丸/冠心病心律失常/系统评价/Meta分析

Key words

Tongxin Yangxin Pills/Coronary Heart Disease with Arrhythmias/Systematic Evaluation/Meta-Analysis

分类

医药卫生

引用本文复制引用

邱璐,丁宇坤,王显..通脉养心丸治疗冠心病心律失常的Meta分析[J].世界中西医结合杂志,2025,20(10):1916-1924,9.

基金项目

国家中医药管理局高水平中医药重点学科建设项目(zyyzdxk-2023259) (zyyzdxk-2023259)

世界中西医结合杂志

1673-6613

访问量0
|
下载量0
段落导航相关论文